Abstract At the 6th World Symposium on Pulmonary Hypertension (PH), it was proposed that
the mean pulmonary arterial pressure (mPAP) threshold used to define PH should be …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Aims Prior studies have not fully characterized the haemodynamic effects of the angiotensin
receptor‐neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved …

Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart
failure and frequently is associated with pulmonary hypertension (PH). HFpEF associated …

Objective Aortic regurgitation (AR) can lead to pulmonary hypertension (PHT). There is a
paucity of data on the prognostic importance of PHT in these patients. We therefore aimed to …

Background and objective Elevated mean pulmonary artery pressure (mPAP) is a significant
prognostic indicator in idiopathic pulmonary fibrosis (IPF). It has been reported that the …

Pulmonary hypertension may develop as a disease process specific to pulmonary arteries
with no identifiable cause or may occur in relation to other cardiopulmonary and systemic …

Left heart disease (LHD) is the most common cause of pulmonary hypertension (PH), which
may be classified further as isolated post-capillary (ipcPH) or combined post-and pre …

Pulmonary hypertension (PH) is an important contributor to morbidity and mortality in
patients with left-sided heart disease, including valvular heart disease. In this context …

Background At the recent 6th World Symposium on Pulmonary Hypertension (PH), the
definition of PH was redefined to include lower pulmonary artery pressures in the setting of …